Evidence map›Paper›PMID 41641965›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Introduction to Supplement Issue: Sensory loss in Alzheimer's disease and related dementias.

Willa D Brenowitz, Joshua R Ehrlich, Jennifer A Deal, Kristine Yaffe

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Willa D BrenowitzKaiser Permanente Center for Health Research, Portland, OR, USA.ORCID 0000-0002-0902-6720
Joshua R EhrlichOphthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-0607-3564
Jennifer A DealDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-6985-048X
Kristine YaffeDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.

Funding

Sensory Aging, Late-Life Wellbeing, and ADRD Research Infrastructure to Catalyze Practice and PolicyR61AG089063 · NIA · JOHNS HOPKINS UNIVERSITY · PI DEAL, JENNIFER ANNE, EHRLICH, JOSHUA ROBERT · 2024 to 2025
$1.6M
NIA NIH HHS R61 AG089063
6 · The paper itself

Abstract

Sensory impairments (e.g., decreased function in hearing, vision, olfaction, and other senses) may be risk factors for or early markers of Alzheimer's disease (AD) and related dementias (ADRD). Sensory impairments are common and have a large impact on wellbeing. Furthermore, they are clinically detectable and, often, treatable, and could be leveraged to identify and prevent AD/ADRD. This Supplement Issue brings together original research articles, reviews, and thought papers regarding the links between sensory impairments and cognitive health. Together, this work highlights the significant opportunities to use sensory information and remediation for earlier diagnosis, treatment, and prevention of dementia.

Indexed as

Alzheimer DiseaseDementiaSensation DisordersHumansAlzheimer's diseasedementiasensory impairmentsensory loss

Identifiers

PMID41641965
PMCPMC13105786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.